Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap Surgery: A Swept Source OCT Analysis.
Macular Holes
About this trial
This is an interventional treatment trial for Macular Holes focused on measuring Large macular hole, Inverted flap surgery, Infracyanine green, Brilliant blue G, Swept source OCT
Eligibility Criteria
Inclusion Criteria:
- Phakic or pseudophakic patients affected with medium to large idiopathic full thickness macular hole (FTMH), with a minimum preoperative diameter of 400 µ
Exclusion Criteria:
- Patients with chorioretinal diseases except FTMH, myopia > 5 D, history of glaucoma, previous trauma or ocular surgery other than cataract extraction, or conditions affecting visual acuity except cataract.
Sites / Locations
- Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
IFCG = Infracyanine Green stained eyes
BBG = Brilliant Peel stained eyes
After removal of core and posterior cortical vitreous and hyaloid stained with 0.2 ml triamcinolone acetonide 40 mg/mL, on the basis of the previous randomization the ILM is stained with 0.2 ml of low-concentration (0.5 mg/mL, 0.05%) IFCG injected over the macular area with the infusion line closed.
After removal of core and posterior cortical vitreous and hyaloid stained with 0.2 ml triamcinolone acetonide 40 mg/mL, on the basis of the previous randomization the ILM is stained with 0.2 mL BBG at a concentration of 0.25 mg/mL (0.025%) injected over the macular area with the infusion line closed.